Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis

NCT06207370 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Babesiosis

Interventions

DRUG: Tafenoquine
OTHER: Placebo

Sponsor

60 Degrees Pharmaceuticals LLC